NovoCure (NVCR) Net Income Growth (3y) (2017 - 2026)
NovoCure (NVCR) Net Income Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 280.49% |
| 10 | NovoCure | 2.00 Bn | 1.56 Bn | 142.48 Mn | 35.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.15% |
| Mar 31, 2026 | -10.27% |
| Dec 31, 2025 | 13.08% |
| Sep 30, 2025 | -11.93% |
| Jun 30, 2025 | -18.69% |
| Mar 31, 2025 | -94.74% |
| Dec 31, 2024 | -35.57% |
| Sep 30, 2024 | -32.56% |
| Jun 30, 2024 | -31.61% |
| Mar 31, 2024 | -110.97% |
| Dec 31, 2023 | -126.21% |
| Sep 30, 2023 | -94.25% |
| Jun 30, 2023 | -232.30% |
| Mar 31, 2023 | -148.94% |
| Dec 31, 2022 | -120.75% |
| Sep 30, 2022 | -150.77% |
| Jun 30, 2022 | -166.39% |
| Mar 31, 2022 | 27.41% |
| Dec 31, 2021 | -19.18% |
| Sep 30, 2021 | -3.92% |